KEYBANK NATIONAL ASSOCIATION/OH - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 310 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
KEYBANK NATIONAL ASSOCIATION/OH ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$674,000
+59.0%
15,000
+100.0%
0.00%0.0%
Q4 2020$424,000
+19.1%
7,5000.0%0.00%0.0%
Q3 2020$356,000
-20.7%
7,500
-1.5%
0.00%
-33.3%
Q2 2020$449,000
+24.7%
7,6170.0%0.00%
+50.0%
Q1 2020$360,000
-56.6%
7,617
-44.6%
0.00%
-50.0%
Q4 2019$830,000
+94.8%
13,739
+93.0%
0.00%
+100.0%
Q3 2019$426,000
-34.0%
7,117
-29.1%
0.00%
-50.0%
Q2 2019$645,000
-53.2%
10,036
-40.9%
0.00%
-50.0%
Q1 2019$1,379,000
+18.1%
16,993
-21.4%
0.01%0.0%
Q4 2018$1,168,000
+6.0%
21,606
+1.2%
0.01%
+33.3%
Q3 2018$1,102,000
+13.4%
21,356
-8.5%
0.01%0.0%
Q2 2018$972,000
-2.3%
23,338
+3.4%
0.01%0.0%
Q1 2018$995,000
+55.2%
22,574
+77.3%
0.01%
+50.0%
Q4 2017$641,000
+49.1%
12,734
+50.2%
0.00%
+33.3%
Q3 2017$430,000
-0.2%
8,4800.0%0.00%0.0%
Q2 2017$431,000
-33.0%
8,480
-47.0%
0.00%
-25.0%
Q1 2017$643,000
-36.0%
16,003
-23.8%
0.00%
-33.3%
Q4 2016$1,005,000
+88.9%
21,004
+44.6%
0.01%
+100.0%
Q3 2016$532,000
+20.9%
14,526
-23.2%
0.00%0.0%
Q2 2016$440,000
+45.7%
18,913
+153.9%
0.00%
+50.0%
Q1 2016$302,000
-53.4%
7,450
-28.8%
0.00%
-50.0%
Q4 2015$648,00010,4640.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders